Abbott Labs Sees Q4 Profit Surge, Beats EPS Expectations

Abbott Laboratories reports strong Q4 results with profit climbing significantly. The company reveals earnings of $9.229 billion, or $5.27 per share, exceeding last year's figures and aligning with analysts' expectations.

Date: 22-01-2025

AI Rating: 7

Financial Performance: Abbott Laboratories recorded impressive fourth-quarter earnings, showing significant growth from the previous year. The reported profit totaled $9.229 billion, an increase from $1.594 billion in the prior year. This results in earnings per share (EPS) of $5.27, a marked improvement from $0.91 the previous year.

Adjusted Earnings: When excluding certain items, the adjusted earnings came to $2.349 billion, or $1.34 per share. This matches analysts’ expectations, suggesting that the company is meeting market forecasts effectively.

Revenue Growth: Revenue for the quarter rose by 7.2%, from $10.241 billion last year to $10.974 billion. This growth demonstrates a positive trend in the company's operations and market performance.

Future Guidance: The guidance for the next quarter indicates an EPS range of $1.05 to $1.09, which continues to show an optimistic outlook for Abbott Laboratories.

Overall, Abbott Laboratories is demonstrating robust financial health, characterized by substantial profit increases, solid EPS performance, and promising revenue growth. These factors are likely to positively influence investor sentiment and could drive stock prices upward.

Stocks: ABT